In collaboration with MycoVita and renowned mycologist Dr. Omon Isikhuemhen, PsyKey has developed proprietary formulas and sourced premium quality bulk mushrooms for an exciting new line of mushroom-infused coffees.
CECORS, INC. (OTC PINK:CEOS), also known as PsyKey, has announced that it has completed the final production of its premium functional mushroom-infused coffee line and will launch its highly anticipated products in conjunction with its new website and integrated e-commerce platform. On Monday, June 20th, 2022, the website will be launched.
PsyKey successfully executed on its goal to develop four functional mushroom-infused coffees that combine 100 percent fair trade organic Arabica coffee beans with the whole dried and ground the fruiting body of adaptogenic, immune-boosting functional mushrooms that are nutritional and antioxidant-rich. Lion’s Mane, Turkey Tail, Chaga, Reishi, Cordyceps, and Maitake are some of the mushroom kinds available. “MIND & MEMORY,” “IMMUNE & DEFEND,” “CALM & RELAXED,” and “REISHI GANO GOOD” are the four functional formulations that have been developed. Consumers will be able to purchase each functional coffee in single-serve coffee pods.
Mr. Amar Bhatal, the President, said that the company’s journey has been successful from “concept to commercialization.” Bhatal also added that the quality and functionality of their single-serve concept is something they are incredibly proud of.
Furthermore, he added that “We have taken our time to make sure that this coffee not only works functionally but provides an incredible taste, something that stands out in the market. This is the first set of offerings in the portfolio – we have been developing other, various unique delivery systems for our proprietary formulations that we would look forward to offering to our consumers. A very exciting time to be a PsyKey shareholder.”
According to Allied Market Research’s analysis report, the global functional mushroom market earned $7.98 billion in 2020 and is expected to reach $19.33 billion by 2030, with a CAGR of 9.3% from 2021 to 2030.
PsyKey will unveil its new website and direct-to-consumer e-commerce platform in conjunction with the completion of manufacturing. Several distribution channels and prospective collaborations were discovered and engaged by PsyKey during the development and production stages to support sales and generate brand recognition. Initial product offers will be offered through PsyKey’s e-commerce website, with more distribution announcements to follow soon.
Featured Image: Megapixl © Kalman89
